CD19 COMPLETE OR PARTIAL LOSS IS A MAJOR MECHANISM OF RELAPSE IN DLBCL PATIENTS TREATED WITH CD19-DIRECTED CAR-T CELLS: EXPERIENCE OF PERUGIA HEMATOLOGY CENTERV. M. Perriello, L. Falini,L. Ruggeri,A. Venanzi, T. Zei, R. Iacucci-Ostini,A. Pierini, S. Ballanti,E. Tiacci,B. FaliniHAEMATOLOGICA（2022）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
